Therefore, targeted suppression of AR expression is the primary treatment for PCa via surgical or medical castration with anti-androgens or luteinizing hormone-releasing hormone analogs (agonists or antagonists)4–7. This evidence concerns the gene AR and posterior cortical atrophy.